Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:30:08.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:06:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error content from the study record page. Also removed the Home navigation item from the footer/navigation.
    Difference
    0.5%
    Check dated 2026-09-27T01:43:02.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content with a standard error page.
    Difference
    19%
    Check dated 2026-09-20T00:47:52.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a newer version of the page content.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:30.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, indicating a newer revision of the study details page was loaded. No substantive content changes are indicated by this revision.
    Difference
    0.1%
    Check dated 2026-08-08T22:36:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.